Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans.

Abstract

BACKGROUND AND AIMS:

Hepatocyte nuclear factor 4 alpha (HNF4α) is indispensable for hepatocyte differentiation and critical for maintaining liver health. Here, we demonstrate that loss of HNF4α activity is a crucial step in the pathogenesis of chronic liver diseases (CLDs) that lead to development of HCC.

APPROACH AND RESULTS:

We developed an HNF4α target gene signature, which can accurately determine HNF4α activity, and performed an exhaustive in silico analysis using hierarchical and K-means clustering, survival, and rank-order analysis of 30 independent data sets containing over 3500 individual samples. The association of changes in HNF4α activity to CLD progression of various etiologies, including HCV- and HBV-induced liver cirrhosis (LC), NAFLD/NASH, and HCC, was determined. Results revealed a step-wise reduction in HNF4α activity with each progressive stage of pathogenesis. Cluster analysis of LC gene expression data sets using the HNF4α signature showed that loss of HNF4α activity was associated with progression of Child-Pugh class, faster decompensation, incidence of HCC, and lower survival with and without HCC. A moderate decrease in HNF4α activity was observed in NAFLD from normal liver, but a further significant decline was observed in patients from NAFLD to NASH. In HCC, loss of HNF4α activity was associated with advanced disease, increased inflammatory changes, portal vein thrombosis, and substantially lower survival.

CONCLUSIONS:

In conclusion, these data indicate that loss of HNF4α function is a common event in the pathogenesis of CLDs leading to HCC and is important from both diagnostic and therapeutic standpoints.

• Authors: Sumedha Gunewardena, Ian Huck, Chad Walesky, Dakota Robarts, Steven Weinman, Udayan Apte
• Journal: Hepatology (Baltimore, Md.) (Hepatology) Vol. 76 Issue 2 Pg. 372-386 (08 2022) ISSN: 1527-3350 [Electronic] United States
• PMID: 35006629 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: © 2022 American Association for the Study of Liver Diseases.

Chemical References

• HNF4A protein, human
• Hepatocyte Nuclear Factor 4

Topics

• Carcinoma, Hepatocellular (pathology)
• Hepatocyte Nuclear Factor 4 (genetics, metabolism)
• Humans
• Liver (pathology)
• Liver Cirrhosis (pathology)
• Liver Neoplasms (pathology)
• Non-alcoholic Fatty Liver Disease (pathology)